On October 10, 2022 Bio-Techne Corporation (NASDAQ: TECH) reported that management will host a conference call and webcast on Tuesday, November 1, 2022, at 8:00 a.m. CDT to review first quarter 2023 financial results (Press release, Bio-Techne, OCT 10, 2022, https://investors.bio-techne.com/news/detail/330/bio-techne-to-host-conference-call-on-november-1-2022-to-announce-first-quarter-2023-financial-results [SID1234621857]).

Schedule your 30 min Free 1stOncology Demo!
Discover why more than 1,500 members use 1stOncology™ to excel in:

Early/Late Stage Pipeline Development - Target Scouting - Clinical Biomarkers - Indication Selection & Expansion - BD&L Contacts - Conference Reports - Combinatorial Drug Settings - Companion Diagnostics - Drug Repositioning - First-in-class Analysis - Competitive Analysis - Deals & Licensing

                  Schedule Your 30 min Free Demo!

A recorded rebroadcast will be available for interested parties unable to participate in the live conference call by dialing 1-844-512-2921 or 1-412-317-6671 (for international callers) and referencing Conference ID 13733551.

The replay will be available from 11:00 a.m. CDT on Tuesday, November 1, 2022, until 11:00 p.m. CST on Thursday, December 1, 2022.